Ventyx Biosciences
A biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high value targets.
Launch date
Employees
Market cap
€138m
Enterprise valuation
(€69m) (Public information from Sep 2024)
Share price
$2.29 VTYX
Encinitas California (HQ)
Authorizing premium user...